Guy G. Brusselle

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 128 publications

Defining minimal clinical disease activity and remission in severe asthma: a modified Delphi consensus.

Defining minimal clinical disease activity and remission in severe asthma: a modified Delphi consensus.

Journal: The journal of allergy and clinical immunology. In practice

Published: December 19, 2025

Obesity and asthma: obesity causes and aggravates asthma across the entire type-2 inflammation spectrum.

Obesity and asthma: obesity causes and aggravates asthma across the entire type-2 inflammation spectrum.

Journal: The European respiratory journal

Published: December 15, 2025

Efficacy of tezepelumab in patients with severe, uncontrolled asthma receiving high-dose inhaled corticosteroids in NAVIGATOR.

Efficacy of tezepelumab in patients with severe, uncontrolled asthma receiving high-dose inhaled corticosteroids in NAVIGATOR.

Journal: The journal of allergy and clinical immunology. In practice

Published: October 10, 2025

Accelerating cancer treatment optimisation: A multistakeholder roadmap from the Cancer Medicines Forum.

Accelerating cancer treatment optimisation: A multistakeholder roadmap from the Cancer Medicines Forum.

Journal: Journal of cancer policy

Published: September 13, 2025

Shaping the Future of Respiratory Care: A Look Into the Next Decade and Strategic Recommendations by European Forum for Research and Education in Allergy and Airways Diseases.

Shaping the Future of Respiratory Care: A Look Into the Next Decade and Strategic Recommendations by European Forum for Research and Education in Allergy and Airways Diseases.

Journal: Chest

Published: August 25, 2025

Type-2 Biomarkers, Asthma Diagnosis and Lung Function Impairment in the General Population.

Type-2 Biomarkers, Asthma Diagnosis and Lung Function Impairment in the General Population.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: June 16, 2025

Biologics in severe asthma: Unmasking EGPA along the way.

Biologics in severe asthma: Unmasking EGPA along the way.

Journal: The journal of allergy and clinical immunology. In practice

Published: April 28, 2025

Preserved ratio impaired spirometry (PRISm): prognostic, preventable and treatable?

Preserved ratio impaired spirometry (PRISm): prognostic, preventable and treatable?

Journal: Thorax

Published: January 26, 2025

Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR).

Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR).

Journal: The World Allergy Organization journal

Published: December 18, 2024

Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024.

Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024.

Journal: Frontiers in allergy

Published: December 05, 2024

Impact of Respiratory and Cardiovascular Drug Exposure on Lung Function Trajectories.

Impact of Respiratory and Cardiovascular Drug Exposure on Lung Function Trajectories.

Journal: Annals of the American Thoracic Society

Published: September 23, 2024

Biologics and airway remodeling in asthma: early, late, and potential preventive effects.

Biologics and airway remodeling in asthma: early, late, and potential preventive effects.

Journal: Allergy

Published: August 25, 2024

Showing 1-12 of 128

Last Updated: 09/26/2026